VCP and neoplasm: Increased VCP protein expression is observed in many cancers and correlates with poor patient outcomes and has been reported to play an important role in autophagy [39,40,41,42], implicating VCP as a promising therapeutic target for which several allosteric and ATP-competitive small molecule inhibitors have been developed with encouraging anti-tumor activity in pre-clinical models [43].